Windtree Therapeutics

Windtree Therapeutics

Biopharmaceuticals(Nasdaq:WINT)

Sobre Windtree Therapeutics

Fundado

1992

Comunidade

Windtree Therapeutics(Nasdaq:WINT) is a clinical-stage biopharmaceutical company focused on the treatment of cardiovascular and respiratory diseases. It develops innovative drugs including Istaroxime and is achieving business transformation and financial stability through building a crypto asset treasury, diversified financing and acquisition strategies.